A randomized, double-blind comparison of beclomethasone dipropionate extrafine aerosol and fluticasone propionate
- 31 May 2001
- journal article
- clinical trial
- Published by Elsevier in Annals of Allergy, Asthma & Immunology
- Vol. 86 (5) , 575-582
- https://doi.org/10.1016/s1081-1206(10)62907-9
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Long-term safety and efficacy of a chlorofluorocarbon-free beclomethasone dipropionate extrafine aerosolAnnals of Allergy, Asthma & Immunology, 2001
- Efficacy response of inhaled beclomethasone dipropionate in asthma is proportional to dose and is improved by formulation with a new propellantJournal of Allergy and Clinical Immunology, 1999
- Hydrofluoroalkane-134a Beclomethasone Dipropionate, 400 μg, Is as Effective as Chlorofluorocarbon Beclomethasone Dipropionate, 800 μg, for the Treatment of Moderate AsthmaChest, 1999
- Inflammatory and Structural Changes in the Small Airways in Bronchial AsthmaAmerican Journal of Respiratory and Critical Care Medicine, 1998
- Assessment of Airway Inflammation in AsthmaAmerican Journal of Respiratory and Critical Care Medicine, 1998
- Efficacy and Safety of Inhaled CorticosteroidsAmerican Journal of Respiratory and Critical Care Medicine, 1998
- Impact of Fluticasone Propionate Powder on Health-Related Quality of Life in Patients with Moderate AsthmaJournal of Asthma, 1997
- Determining a minimal important change in a disease-specific quality of life questionnaireJournal of Clinical Epidemiology, 1994
- Evaluation of impairment of health related quality of life in asthma: development of a questionnaire for use in clinical trials.Thorax, 1992
- A comparison of the Two One-Sided Tests Procedure and the Power Approach for assessing the equivalence of average bioavailabilityJournal of Pharmacokinetics and Biopharmaceutics, 1987